|  Help  |  About  |  Contact Us

Publication : Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression.

First Author  Liu Z Year  2014
Journal  Cancer Cell Volume  26
Issue  1 Pages  106-20
PubMed ID  25026213 Mgi Jnum  J:214231
Mgi Id  MGI:5588603 Doi  10.1016/j.ccr.2014.05.015
Citation  Liu Z, et al. (2014) Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell 26(1):106-20
abstractText  In selective autophagy, receptors are central for cargo selection and delivery. However, it remains yet unclear whether and how multiple autophagy receptors might form complex and function concertedly to control autophagy. Optineurin (OPTN), implicated genetically in glaucoma and amyotrophic lateral sclerosis, was a recently identified autophagy receptor. Here we report that tumor-suppressor HACE1, a ubiquitin ligase, ubiquitylates OPTN and promotes its interaction with p62/SQSTM1 to form the autophagy receptor complex, thus accelerating autophagic flux. Interestingly, the Lys48-linked polyubiquitin chains that HACE1 conjugates onto OPTN might predominantly target OPTN for autophagic degradation. By demonstrating that the HACE1-OPTN axis synergistically suppresses growth and tumorigenicity of lung cancer cells, our findings may open an avenue for developing autophagy-targeted therapeutic intervention into cancer.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression